References

Adembri, C., Venturi, L., & Pellegrini-Giampietro, D. E. (2007). Neuroprotective effects of propofol in acute cerebral injury. CNS Drug Rev, 13(3), 333-351.

Al-Adawi, S., Hoaglin, H., Vesali, F., Dorvlo, A. S., & Burke, D. T. (2009). Effect of amantadine on the sleep-wake cycle of an inpatient with brain injury. Brain Inj, 23(6), 559-565.

Albanese, J., Durbec, O., Viviand, X., Potie, F., Alliez, B., & Martin, C. (1993). Sufentanil increases intracranial pressure in patients with head trauma. Anesthesiology, 79(3), 493-497.

Albanese, J., Viviand, X., Potie, F., Rey, M., Alliez, B., & Martin, C. (1999). Sufentanil, fentanyl, and alfentanil in head trauma patients: a study on cerebral hemodynamics. Crit Care Med, 27(2), 407-411.

Alderson, P., & Roberts, I. (1997). Corticosteroids in acute traumatic brain injury: systematic review of randomised controlled trials. BMJ, 314(7098), 1855-1859.

Alderson, P., & Roberts, I. (2005). Corticosteroids for acute traumatic brain injury. Cochrane Database Syst Rev, 1, Cd000196.

Alvarez, X. A., Sampedro, C., Perez, P., Laredo, M., Couceiro, V., Hernandez, A., . . . Moessler, H. (2003). Positive effects of cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory study. Int Clin Psychopharmacol, 18(5), 271-278.

Ashman, T. A., Cantor, J. B., Gordon, W. A., Spielman, L., Flanagan, S., Ginsberg, A., . . . Greenwald, B. (2009). A Randomized Controlled Trial of Sertraline for the Treatment of Depression in Persons With Traumatic Brain Injury. Arch Phys Med Rehabil, 90(5), 733-740.

Azouvi, P., Jokic, C., Attal, N., Denys, P., Markabi, S., & Bussel, B. (1999). Carbamazepine in agitation and aggressive behaviour following severe closed-head injury: Results of an open trial. Brain Inj, 13(10), 797-804.

Battison, C., Andrews, P. J., Graham, C., & Petty, T. (2005). Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med, 33(1), 196-202.

Beauchamp, K., Mutlak, H., Smith, W. R., Shohami, E., & Stahel, P. F. (2008). Pharmacology of Traumatic Brain Injury: Where Is the “Golden Bullet”? Molecular Medicine, 14(11-12), 731-740.

Becker, R., Alberti, O., & Bauer, B. L. (1997). Continuous intrathecal baclofen infusion in severe spasticity after traumatic or hypoxic brain injury. J Neurol, 244(3), 160-166.

Beusterien, K. M., Rogers, A. E., Walsleben, J. A., Emsellem, H. A., Reblando, J. A., Wang, L., . . . Steinwald, B. (1999). Health-related quality of life effects of modafinil for treatment of narcolepsy. Sleep, 22(6), 757-765.

Bhullar, I. S., Johnson, D., Paul, J. P., Kerwin, A. J., Tepas 3rd, J. J., & Frykberg, E. R. (2014). More harm than good: Antiseizure prophylaxis after traumatic brain injury does not decrease seizure rates but may inhibit functional recovery. J Trauma Acute Care Surg, 76(1), 54-61.

Braakman, R., Schouten, H. J., Blaauw-van Dishoeck, M., & Minderhoud, J. M. (1983). Megadose steroids in severe head injury. Results of a prospective double-blind clinical trial. J Neurosurg, 58(3), 326-330.

Bratton, S. L., Chestnut, R. M., Ghajar, J., McConnell Hammond, F. F., Harris, O. A., Hartl, R., . . . Wright, D. W. (2007). Guidelines for the management of severe traumatic brain injury. III. Prophylactic hypothermia. J Neurotrauma, 24(Suppl 1), S21-25.

Brooke, M. M., Questad, K. A., Patterson, D. R., & Bashak, K. J. (1992). Agitation and restlessness after closed head injury: A prospective study of 100 consecutive admissions. Arch Phys Med Rehabil, 73(4), 320-323.

Bunegin, L., Albin, M. S., Ernst, P. S., & Garcia, C. (1989). Cerebrovascular responses to sufentanil citrate (SC) in primates with and without intracranial hypertension. J Neurosurg Anesthesiol, 1(2), 138-139.

Cardenas, D. D., McLean, A., Jr., Farrell-Roberts, L., Baker, L., Brooke, M., & Haselkorn, J. (1994). Oral physostigmine and impaired memory in adults with brain injury. Brain Inj, 8(7), 579-587.

Chahine, L. M., & Chemali, Z. (2006). Du rire aux larmes: Pathological laughing and crying in patients with traumatic brain injury and treatment with lamotrigine. Epilepsy Behav, 8(3), 610-615.

Chatham Showalter, P. E., & Kimmel, D. N. (2000). Agitated symptom response to divalproex following acute brain injury. J Neuropsychiatry Clin Neurosci, 12(3), 395-397.

Clemenzi, A., Formisano, R., Matteis, M., Gallinacci, L., Cochi, G., Savina, P., & Cicinelli, P. (2012). Care management of spasticity with botulinum toxin-A in patients with severe acquired brain injury: a 1-year follow-up prospective study. Brain Inj, 26(7-8), 979-983.

Colton, K., Yang, S., Hu, P. F., Chen, H. H., Bonds, B., Scalea, T. M., & Stein, D. M. (2014). Intracranial pressure response after pharmacologic treatment of intracranial hypertension. J Trauma Acute Care Surg, 77(1), 47-53.

Cooper, P. R., Moody, S., Clark, W. K., Kirkpatrick, J., Maravilla, K., Gould, A. L., & Drane, W. (1979). Dexamethasone and severe head injury. A prospective double-blind study. J Neurosurg, 51(3), 307-316.

Cruz, J., Minoja, G., & Okuchi, K. (2001). Improving clinical outcomes from acute subdural hematomas with the emergency preoperative administration of high doses of mannitol: a randomized trial. Neurosurgery, 49(4), 864-871.

Cruz, J., Minoja, G., & Okuchi, K. (2002). Major clinical and physiological benefits of early high doses of mannitol for intraparenchymal temporal lobe hemorrhages with abnormal pupillary widening: a randomized trial. Neurosurgery, 51(3), 628-637.

Cruz, J., Minoja, G., Okuchi, K., & Facco, E. (2004). Successful use of the new high-dose mannitol treatment in patients with Glasgow Coma Scale scores of 3 and bilateral abnormal pupillary widening: a randomized trial. J Neurosurg, 100(3), 376-383.

Dario, A., Di Stefano, M. G., Grossi, A., Casagrande, F., & Bono, G. (2002). Long-term intrathecal Baclofen infusion in supraspinal spasticity of adulthood. Acta Neurol Scand, 105(2), 83-87.

Davis, D. P., Kimbro, T. A., & Vilke, G. M. (2001). The use of midazolam for prehospital rapid-sequence intubation may be associated with a dose-related increase in hypotension. Prehosp Emerg Care, 5(2), 163-168.

de Nadal, M., Munar, F., Poca, M. A., Sahuquillo, J., Garnacho, A., & Rossello, J. (2000). Cerebral hemodynamic effects of morphine and fentanyl in patients with severe head injury: absence of correlation to cerebral autoregulation. Anesthesiology, 92(1), 11-19.

Dearden, N. M., Gibson, J. S., McDowall, D. G., Gibson, R. M., & Cameron, M. M. (1986). Effect of high-dose dexamethasone on outcome from severe head injury. J Neurosurg, 64(1), 81-88.

Dikmen, S. S., Machamer, J. E., Winn, H. R., Anderson, G. D., & Temkin, N. R. (2000). Neuropsychological effects of valproate in traumatic brain injury: a randomized trial. Neurology, 54(4), 895-902.

Dikmen, S. S., Temkin, N. R., Miller, B., Machamer, J., & Winn, H. R. (1991). Neurobehavioral effects of phenytoin prophylaxis of posttraumatic seizures. JAMA, 265(10), 1271-1277.

Diringer, M. N., Scalfani, M. T., Zazulia, A. R., Videen, T. O., Dhar, R., & Powers, W. J. (2012). Effect of mannitol on cerebral blood volume in patients with head injury. Neurosurgery, 70(5), 1215-1218.

Eisenberg, H. M., Frankowski, R. F., Contant, C. F., Marshall, L. F., & Walker, M. D. (1988). High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury. J Neurosurg, 69(1), 15-23.

Emory, L. E., Cole, C. M., & Meyer, W. J. (1995). Use of Depo-Provera to control sexual aggression in persons with traumatic brain injury. J Head Trauma Rehabil, 10(3), 47-58.

Engelhard, K., Reeker, W., Kochs, E., & Werner, C. (2004). Effect of remifentanil on intracranial pressure and cerebral blood flow velocity in patients with head trauma. Acta Anaesthesiol Scand, 48(4), 396-399.

Eshhar, N., Striem, S., Kohen, R., Tirosh, O., & Biegon, A. (1995). Neuroprotective and antioxidant activities of HU-211, a novel NMDA receptor antagonist. Eur J Pharmacol, 283(1-3), 19-29.

Fanconi, S., Kloti, J., Meuli, M., Zaugg, H., & Zachmann, M. (1988). Dexamethasone therapy and endogenous cortisol production in severe pediatric head injury. Intensive Care Med, 14(2), 163-166.

Farling, P. A., Johnston, J. R., & Coppel, D. L. (1989). Propofol infusion for sedation of patients with head injury in intensive care. A preliminary report. Anaesthesia, 44(3), 222-226.

Feigenbaum, J. J., Bergmann, F., Richmond, S. A., Mechoulam, R., Nadler, V., Kloog, Y., & Sokolovsky, M. (1989). Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker. Proc Natl Acad Sci U S A, 86(23), 9584-9587.

Ferguson, P. L., Smith, G. M., Wannamaker, B. B., Thurman, D. J., Pickelsimer, E. E., & Selassie, A. W. (2010). A population-based study of risk of epilepsy after hospitalization for traumatic brain injury. Epilepsia, 51(5), 891-898.

Firsching, R., Piek, J., Skalej, M., Rohde, V., Schmidt, U., & Striggow, F. (2012). Early survival of comatose patients after severe traumatic brain injury with the dual cannabinoid CB1/CB2 receptor agonist KN38-7271: a randomized, double-blind, placebo-controlled phase II trial. J Neurol Surg A Cent Eur Neurosurg, 73(4), 204-216.

Fock, J., Galea, M. P., Stillman, B. C., Rawicki, B., & Clark, M. (2004). Functional outcome following Botulinum toxin A injection to reduce spastic equinus in adults with traumatic brain injury. Brain Inj, 18(1), 57-63.

Formisano, R., Barba, C., Buzzi, M. G., Newcomb-Fernandez, J., Menniti-Ippolito, F., Zafonte, R., . . . Spanedda, F. (2007). The impact of prophylactic treatment on post-traumatic epilepsy after severe traumatic brain injury. Brain Inj, 21(5), 499-504.

Francisco, G. E., Hu, M. M., Boake, C., & Ivanhoe, C. B. (2005). Efficacy of early use of intrathecal baclofen therapy for treating spastic hypertonia due to acquired brain injury. Brain Inj, 19(5), 359-364.

Francois, B., Vacher, P., Roustan, J., Salle, J. Y., Vidal, J., Moreau, J. J., & Vignon, P. (2001). Intrathecal baclofen after traumatic brain injury: early treatment using a new technique to prevent spasticity. J Trauma, 50(1), 158-161.

Francony, G., Fauvage, B., Falcon, D., Canet, C., Dilou, H., Lavagne, P., . . . Payen, J. F. (2008). Equimolar doses of mannitol and hypertonic saline in the treatment of increased intracranial pressure. Crit Care Med, 36(3), 795-800.

Fried, R. C., Dickerson, R. N., Guenter, P. A., Stein, T. P., Gennarelli, T. A., Dempsey, D. T., . . . Mullen, J. L. (1989). Barbiturate therapy reduces nitrogen excretion in acute head injury. J Trauma, 29(11), 1558-1564.

Gabriel, W. M., & Rowe, A. S. (2014). Long-term comparison of GOS-E scores in patients treated with phenytoin or levetiracetam for posttraumatic seizure prophylaxis after traumatic brain injury. Ann Pharmacother, 48(11), 1440-1444.

Gao, K., & Calabrese, J. R. (2005). Newer treatment studies for bipolar depression. Bipolar Disord, 7(Suppl 5), 13-23.

Garland, D. E., Lilling, M., & Keenan, M. A. (1984). Percutaneous phenol blocks to motor points of spastic forearm muscles in head-injured adults. Arch Phys Med Rehabil, 65(5), 243-245.

Geracioti Jr, T. D. (1994). Valproic acid treatment of episodic explosiveness related to brain injury [4]. J Clin Psychiatry, 55(9), 416-417.

Giannotta, S. L., Weiss, M. H., Apuzzo, M. L., & Martin, E. (1984). High dose glucocorticoids in the management of severe head injury. Neurosurgery, 15(4), 497-501.

Glenn, M. B. (1998). Methylphenidate for cognitive and behavioral dysfunction after traumatic brain injury. J Head Trauma Rehabil, 13(5), 87-90.

Glenn, M. B., Wroblewski, B., Parziale, J., Levine, L., Whyte, J., & Rosenthal, M. (1989). Lithium carbonate for aggressive behavior or affective instability in ten brain-injured patients. Am J Phys Med Rehabil, 68(5), 221-226.

Gormley, M. E., Jr., O'Brien, C. F., & Yablon, S. A. (1997). A clinical overview of treatment decisions in the management of spasticity. Muscle Nerve, 20(Suppl 6), S14-20.

Gracies, J. M., Elovic, E., McGuire, J., & Simpson, D. M. (1997). Traditional pharmacological treatments for spasticity. Part I: Local treatments. Muscle Nerve, 20(Suppl 6), S61-91.

Gracies, J. M., Nance, P., Elovic, E., McGuire, J., & Simpson, D. M. (1997). Traditional pharmacological treatments for spasticity. Part II: General and regional treatments. Muscle Nerve, 20(Suppl 6), S92-120.

Green, L. B., Hornyak, J. E., & Hurvitz, E. A. (2004). Amantadine in pediatric patients with traumatic brain injury: a retrospective, case-controlled study. Am J Phys Med Rehabil, 83(12), 893-897.

Greendyke, R. M., & Kanter, D. R. (1986). Therapeutic effects of pindolol on behavioral disturbances associated with organic brain disease: A double-blind study. J Clin Psychiatry, 47(8), 423-426.

Greendyke, R. M., Kanter, D. R., Schuster, D. B., Verstreate, S., & Wootton, J. (1986). Propranolol treatment of assaultive patients with organic brain disease. A double-blind crossover, placebo-controlled study. J Nerv Ment Dis, 174(5), 290-294.

Groswasser, Z., Cohen, M., & Keren, O. (1998). Female TBI patients recover better than males. Brain Inj, 12(9), 805-808.

Grumme, T., Baethmann, A., Kolodziejczyk, D., Krimmer, J., Fischer, M., von Eisenhart Rothe, B., . . . et al. (1995). Treatment of patients with severe head injury by triamcinolone: a prospective, controlled multicenter clinical trial of 396 cases. Res Exp Med (Berl), 195(4), 217-229.

Hartl, R., Bardt, T. F., Kiening, K. L., Sarrafzadeh, A. S., Schneider, G. H., & Unterberg, A. W. (1997). Mannitol decreases ICP but does not improve brain-tissue pO2 in severely head-injured patients with intracranial hypertension. Acta Neurochir Suppl, 70, 40-42.

Hoarau, X., Richer, E., Dehail, P., & Cuny, E. (2012a). A 10-year follow-up study of patients with severe traumatic brain injury and dysautonomia treated with intrathecal baclofen therapy. Brain Inj, 26(7-8), 927-940.

Hoarau, X., Richer, E., Dehail, P., & Cuny, E. (2012b). Comparison of long-term outcomes of patients with severe traumatic or hypoxic brain injuries treated with intrathecal baclofen therapy for dysautonomia. Brain Inj, 26(12), 1451-1463.

Horn, T. S., Yablon, S. A., Chow, J. W., Lee, J. E., & Stokic, D. S. (2010). Effect of intrathecal baclofen bolus injection on lower extremity joint range of motion during gait in patients with acquired brain injury. Arch Phys Med Rehabil, 91(1), 30-34.

Horn, T. S., Yablon, S. A., & Stokic, D. S. (2005). Effect of intrathecal baclofen bolus injection on temporospatial gait characteristics in patients with acquired brain injury. Arch Phys Med Rehabil, 86(6), 1127-1133.

Hornyak, J. E., Nelson, V. S., & Hurvitz, E. A. (1997). The use of methylphenidate in paediatric traumatic brain injury. Pediatr Rehabil, 1(1), 15-17.

Hughes, S., Colantonio, A., Santaguida, P. L., & Paton, T. (2005). Amantadine to enhance readiness for rehabilitation following severe traumatic brain injury. Brain Inj, 19(14), 1197-1206.

Ichai, C., Armando, G., Orban, J. C., Berthier, F., Rami, L., Samat-Long, C., . . . Leverve, X. (2009). Sodium lactate versus mannitol in the treatment of intracranial hypertensive episodes in severe traumatic brain-injured patients. Intensive Care Med, 35(3), 471-479.

Inaba, K., Menaker, J., Branco, B. C., Gooch, J., Okoye, O. T., Herrold, J., . . . Demetriades, D. (2013). A prospective multicenter comparison of levetiracetam versus phenytoin for early posttraumatic seizure prophylaxis. J Trauma Acute Care Surg, 74(3), 766-771.

Intiso, D., Simone, V., Di Rienzo, F., Iarossi, A., Pazienza, L., Santamato, A., . . . Basciani, M. (2014). High doses of a new botulinum toxin type A (NT-201) in adult patients with severe spasticity following brain injury and cerebral palsy. NeuroRehabilitation, 34(3), 515-522.

James, M. L., Olson, D. M., & Graffagnino, C. (2012). A pilot study of cerebral and haemodynamic physiological changes during sedation with dexmedetomidine or propofol in patients with acute brain injury. Anaesth Intensive Care, 40(6), 949-957.

Jankovic, J., & Brin, M. F. (1991). Therapeutic uses of botulinum toxin. N Engl J Med, 324(17), 1186-1194.

Jha, A., Weintraub, A., Allshouse, A., Morey, C., Cusick, C., Kittelson, J., . . . Gerber, D. (2008). A randomized trial of modafinil for the treatment of fatigue and excessive daytime sleepiness in individuals with chronic traumatic brain injury. J Head Trauma Rehabil, 23(1), 52-63.

Jones, K. E., Puccio, A. M., Harshman, K. J., Falcione, B., Benedict, N., Jankowitz, B. T., . . . Okonkwo, D. O. (2008). Levetiracetam versus phenytoin for seizure prophylaxis in severe traumatic brain injury. Neurosurg Focus, 25(4), E3.

Jorge, R. E., Robinson, R. G., Moser, D., Tateno, A., Crespo-Facorro, B., & Arndt, S. (2004). MAjor depression following traumatic brain injury. Arch Gen Psychiatry, 61(1), 42-50.

Kaiser, P. R., Valko, P. O., Werth, E., Thomann, J., Meier, J., Stocker, R., . . . Baumann, C. R. (2010). Modafinil ameliorates excessive daytime sleepiness after traumatic brain injury. Neurology, 75(20), 1780-1785.

Kaktis, J. V., & Pitts, L. H. (1980). Complications associated with use of megadose corticosteroids in head-injured adults. J Neurosurg Nurs, 12(3), 166-171.

Kant, R., Smith-Seemiller, L., & Zeiler, D. (1998). Treatment of aggression and irritability after head injury. Brain Inj, 12(8), 661-666.

Karabinis, A., Mandragos, K., Stergiopoulos, S., Komnos, A., Soukup, J., Speelberg, B., & Kirkham, A. J. (2004). Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial [ISRCTN50308308]. Crit Care, 8(4), R268-280.

Katz, R. T., & Compagnolo, D. I. (1993). Pharmacological management of spasticity. In R. T. Katz (Ed.), Spasticity: State of the Art Reviews; Physical Medicine and Rehabilitation (Vol. 8, pp. 473-480). Philadelphia, PA: Hanley and Belfus.

Katz, R. T., Dewald, J. P., & Schmit, B. D. (2000). Spasticity. In R. L. Braddom (Ed.), Physical Medicine and Rehabilitation (pp. 592-615). Toronto, ON: Saunders Company.

Keenan, M. A., Tomas, E. S., Stone, L., & Gersten, L. M. (1990). Percutaneous phenol block of the musculocutaneous nerve to control elbow flexor spasticity. J Hand Surg Am, 15(2), 340-346.

Kelly, D. F., Goodale, D. B., Williams, J., Herr, D. L., Chappell, E. T., Rosner, M. J., . . . Narayan, R. K. (1999). Propofol in the treatment of moderate and severe head injury: a randomized, prospective double-blinded pilot trial. J Neurosurg, 90(6), 1042-1052.

Kempton, S., Vance, A., Maruff, P., Luk, E., Costin, J., & Pantelis, C. (1999). Executive function and attention deficit hyperactivity disorder: stimulant medication and better executive function performance in children. Psychol Med, 29(3), 527-538.

Khateb, A., Ammann, J., Annoni, J. M., & Diserens, K. (2005). Cognition-enhancing effects of donepezil in traumatic brain injury. Eur Neurol, 54(1), 39-45.

Kim, E. (2002). Agitation, aggression, and disinhibition syndromes after traumatic brain injury. NeuroRehabilitation, 17(4), 297-310.

Kim, E., & Bijlani, M. (2006). A pilot study of quetiapine treatment of aggression due to traumatic brain injury. J Neuropsychiatry Clin Neurosci, 18(4), 547-549.

Kim, J., Whyte, J., Patel, S., Europa, E., Wang, J., Coslett, H. B., & Detre, J. A. (2012). Methylphenidate modulates sustained attention and cortical activation in survivors of traumatic brain injury: a perfusion fMRI study. Psychopharmacology (Berl), 222(1), 47-57.

Kim, Y. H., Ko, M. H., Na, S. Y., Park, S. H., & Kim, K. W. (2006). Effects of single-dose methylphenidate on cognitive performance in patients with traumatic brain injury: a double-blind placebo-controlled study. Clin Rehabil, 20(1), 24-30.

Kjaersgaard-Andersen, P., & Schmidt, S. A. (1986). Indomethacin for prevention of ectopic ossification after hip arthroplasty. Acta Orthop Scand, 57(1), 12-14.

Kline, A. E., Massucci, J. L., Marion, D. W., & Dixon, C. E. (2002). Attenuation of working memory and spatial acquisition deficits after a delayed and chronic bromocriptine treatment regimen in rats subjected to traumatic brain injury by controlled cortical impact. J Neurotrauma, 19(4), 415-425.

Kloti, J., Fanconi, S., Zachmann, M., & Zaugg, H. (1987). Dexamethasone therapy and cortisol excretion in severe pediatric head injury. Childs Nerv Syst, 3(2), 103-105.

Knoller, N., Levi, L., Shoshan, I., Reichenthal, E., Razon, N., Rappaport, Z. H., & Biegon, A. (2002). Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo-controlled, phase II clinical trial. Crit Care Med, 30(3), 548-554.

Kraus, M. F., Smith, G. S., Butters, M., Donnell, A. J., Dixon, E., Yilong, C., & Marion, D. (2005). Effects of the dopaminergic agent and NMDA receptor antagonist amantadine on cognitive function, cerebral glucose metabolism and D2 receptor availability in chronic traumatic brain injury: a study using positron emission tomography (PET). Brain Inj, 19(7), 471-479.

Kruer, R. M., Harris, L. H., Goodwin, H., Kornbluth, J., Thomas, K. P., Slater, L. A., & Haut, E. R. (2013). Changing trends in the use of seizure prophylaxis after traumatic brain injury: a shift from phenytoin to levetiracetam. J Crit Care, 28(5), 883.e9-13.

Lance, J. W. (1980). The control of muscle tone, reflexes, and movement: Robert Wartenberg Lecture. Neurology, 30(12), 1303-1313.

Lauer, K. K., Connolly, L. A., & Schmeling, W. T. (1997). Opioid sedation does not alter intracranial pressure in head injured patients. Can J Anaesth, 44(9), 929-933.

Lee, H., Kim, S. W., Shin, I. S., Yang, S. J., & Yoon, J. S. (2005). Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury. Hum Psychopharmacol, 20(2), 97-104.

Leonard, B. E., McCartan, D., White, J., & King, D. J. (2004). Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmacol, 19(3), 151-180.

Levy, M., Berson, A., Cook, T., Bollegala, N., Seto, E., Tursanski, S., . . . Bhalerao, S. (2005). Treatment of agitation following traumatic brain injury: A review of the literature. NeuroRehabilitation, 20(4), 279-306.

Llompart-Pou, J. A., Perez-Barcena, J., Raurich, J. M., Burguera, B., Ayestaran, J. I., Abadal, J. M., . . . Ibanez, J. (2007). Effect of barbiturate coma on adrenal response in patients with traumatic brain injury. J Endocrinol Invest, 30(5), 393-398.

Maas, A. I., Dearden, M., Teasdale, G. M., Braakman, R., Cohadon, F., Iannotti, F., . . . Unterberg, A. (1997). EBIC-guidelines for management of severe head injury in adults. European Brain Injury Consortium. Acta Neurochir (Wien), 139(4), 286-294.

Maas, A. I., Murray, G., Henney, H., 3rd, Kassem, N., Legrand, V., Mangelus, M., . . . Knoller, N. (2006). Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial. Lancet Neurol, 5(1), 38-45.

Mahalick, D. M., Carmel, P. W., Greenberg, J. P., Molofsky, W., Brown, J. A., Heary, R. F., . . . von der Schmidt, E., 3rd. (1998). Psychopharmacologic treatment of acquired attention disorders in children with brain injury. Pediatr Neurosurg, 29(3), 121-126.

Majdan, M., Mauritz, W., Wilbacher, I., Brazinova, A., Rusnak, M., & Leitgeb, J. (2013). Barbiturates use and its effects in patients with severe traumatic brain injury in five European countries. J Neurotrauma, 30(1), 23-29.

Manaka, S. (1992). Cooperative prospective study on posttraumatic epilepsy: risk factors and the effect of prophylactic anticonvulsant. Jpn J Psychiatry Neurol, 46(2), 311-315.

Mania, I., Evcimen, H., & Mathews, M. (2006). Citalopram treatment for inappropriate sexual behavior in a cognitively impaired patient. Prim Care Companion J Clin Psychiatry, 8(2), 106-107.

Marshall, L. F., Smith, R. W., & Shapiro, H. M. (1979). The outcome with aggressive treatment in severe head injuries. Part II: acute and chronic barbiturate administration in the management of head injury. J Neurosurg, 50(1), 26-30.

Marx, W., Shah, N., Long, C., Arbit, E., Galicich, J., Mascott, C., . . . Bedford, R. (1989). Sufentanil, alfentanil, and fentanyl: impact on cerebrospinal fluid pressure in patients with brain tumors. J Neurosurg Anesthesiol, 1(1), 3-7.

Masanic, C. A., Bayley, M. T., VanReekum, R., & Simard, M. (2001). Open-label study of donepezil in traumatic brain injury. Arch Phys Med Rehabil, 82(7), 896-901.

Mayer, N. H., Whyte, J., Wannstedt, G., & Ellis, C. A. (2008). Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia. Arch Phys Med Rehabil, 89(5), 982-987.

McClelland, M., Woster, P., Sweasey, T., & Hoff, J. T. (1995). Continuous midazolam/atracurium infusions for the management of increased intracranial pressure. J Neurosci Nurs, 27(2), 96-101.

McDowell, S., Whyte, J., & D'Esposito, M. (1998). Differential effect of a dopaminergic agonist on prefrontal function in traumatic brain injury patients. Brain, 121 (Pt 6), 1155-1164.

McElroy, S. L., Keck, P. E., Jr., & Pope, H. G., Jr. (1987). Sodium valproate: its use in primary psychiatric disorders. J Clin Psychopharmacol, 7(1), 16-24.

McGuinness, S., Hillan, J., & Caldwell, S. B. (2013). Botulinum toxin in gait dysfunction due to ankle clonus: A case series. NeuroRehabilitation, 32(3), 635-647.

McLean, A., Jr., Stanton, K. M., Cardenas, D. D., & Bergerud, D. B. (1987). Memory training combined with the use of oral physostigmine. Brain Inj, 1(2), 145-159.

McMahon, M. A., Vargus-Adams, J. N., Michaud, L. J., & Bean, J. (2009). Effects of amantadine in children with impaired consciousness caused by acquired brain injury: a pilot study. Am J Phys Med Rehabil, 88(7), 525-532.

McQueen, J. K., Blackwood, D. H. R., Harris, P., Kalbag, R. M., & Johnson, A. L. (1983). Low risk of late post-traumatic seizures following severe head injury: Implications for clinical trials of prophylaxis. J Neurol Neurosurg Psychiatry, 46(10), 899-904.

Mechoulam, R., Feigenbaum, J. J., Lander, N., Segal, M., Jarbe, T. U., Hiltunen, A. J., & Consroe, P. (1988). Enantiomeric cannabinoids: stereospecificity of psychotropic activity. Experientia, 44(9), 762-764.

Metz, C., Gobel, L., Gruber, M., Hoerauf, K. H., & Taeger, K. (2000). Pharmacokinetics of human cerebral opioid extraction: a comparative study on sufentanil, fentanyl, and alfentanil in a patient after severe head injury. Anesthesiology, 92(6), 1559-1567.

Meythaler, J. M., Brunner, R. C., Johnson, A., & Novack, T. A. (2002). Amantadine to improve neurorecovery in traumatic brain injury-associated diffuse axonal injury: a pilot double-blind randomized trial. J Head Trauma Rehabil, 17(4), 300-313.

Meythaler, J. M., Clayton, W., Davis, L. K., Guin-Renfroe, S., & Brunner, R. C. (2004). Orally delivered baclofen to control spastic hypertonia in acquired brain injury. J Head Trauma Rehabil, 19(2), 101-108.

Meythaler, J. M., DeVivo, M. J., & Hadley, M. (1996). Prospective study on the use of bolus intrathecal baclofen for spastic hypertonia due to acquired brain injury. Arch Phys Med Rehabil, 77(5), 461-466.

Meythaler, J. M., Guin-Renfroe, S., Grabb, P., & Hadley, M. N. (1999). Long-term continuously infused intrathecal baclofen for spastic-dystonic hypertonia in traumatic brain injury: 1-year experience. Arch Phys Med Rehabil, 80(1), 13-19.

Meythaler, J. M., Guin-Renfroe, S., & Hadley, M. N. (1999). Continuously infused intrathecal baclofen for spastic/dystonic hemiplegia: a preliminary report. Am J Phys Med Rehabil, 78(3), 247-254.

Meythaler, J. M., Guin-Renfroe, S., Johnson, A., & Brunner, R. M. (2001). Prospective assessment of tizanidine for spasticity due to acquired brain injury. Arch Phys Med Rehabil, 82(9), 1155-1163.

Meythaler, J. M., McCary, A., & Hadley, M. N. (1997). Prospective assessment of continuous intrathecal infusion of baclofen for spasticity caused by acquired brain injury: a preliminary report. J Neurosurg, 87(3), 415-419.

Morey, C. E., Cilo, M., Berry, J., & Cusick, C. (2003). The effect of Aricept in persons with persistent memory disorder following traumatic brain injury: a pilot study. Brain Inj, 17(9), 809-815.

Moseley, A. M., Herbert, R. D., Sherrington, C., & Maher, C. G. (2002). Evidence for physiotherapy practice: a survey of the Physiotherapy Evidence Database (PEDro). Aust J Physiother, 48(1), 43-49.

Mysiw, W. J., Jackson, R. D., & Corrigan, J. D. (1988). Amitriptyline for post-traumatic agitation. Am J Phys Med Rehabil, 67(1), 29-33.

Napolitano, E., Elovic, E. P., & Qureshi, A. I. (2005). Pharmacological stimulant treatment of neurocognitive and functional deficits after traumatic and non-traumatic brain injury. Med Sci Monit, 11(6), Ra212-220.

Noé, E., Ferri, J., Trénor, C., & Chirivella, J. (2007). Efficacy of ziprasidone in controlling agitation during post-traumatic amnesia. Behav Neurol, 18(1), 7-11.

Nordby, H. K., & Nesbakken, R. (1984). The effect of high dose barbiturate decompression after severe head injury. A controlled clinical trial. Acta Neurochir (Wien), 72(3-4), 157-166.

Pagni, C. A., & Zenga, F. (2005). Posttraumatic epilepsy with special emphasis on prophylaxis and prevention. Acta Neurochir Suppl, 93, 27-34.

Papazian, L., Albanese, J., Thirion, X., Perrin, G., Durbec, O., & Martin, C. (1993). Effect of bolus doses of midazolam on intracranial pressure and cerebral perfusion pressure in patients with severe head injury. Br J Anaesth, 71(2), 267-271.

Patrick, P. D., Blackman, J. A., Mabry, J. L., Buck, M. L., Gurka, M. J., & Conaway, M. R. (2006). Dopamine agonist therapy in low-response children following traumatic brain injury. J Child Neurol, 21(10), 879-885.

Patrick, P. D., Buck, M. L., Conaway, M. R., & Blackman, J. A. (2003). The use of dopamine enhancing medications with children in low response states following brain injury. Brain Inj, 17(6), 497-506.

Perino, C., Rago, R., Cicolin, A., Torta, R., & Monaco, F. (2001). Mood and behavioural disorders following traumatic brain injury: Clinical evaluation and pharmacological management. Brain Inj, 15(2), 139-148.

Plenger, P. M., Dixon, C. E., Castillo, R. M., Frankowski, R. F., Yablon, S. A., & Levin, H. S. (1996). Subacute methylphenidate treatment for moderate to moderately severe traumatic brain injury: a preliminary double-blind placebo-controlled study. Arch Phys Med Rehabil, 77(6), 536-540.

Posteraro, F., Calandriello, B., Galli, R., Logi, F., Iardella, L., & Bordi, L. (2013). Timing of intrathecal baclofen therapy in persons with acquired brain injury: influence on outcome. Brain Inj, 27(13-14), 1671-1675.

Powell, J. H., al-Adawi, S., Morgan, J., & Greenwood, R. J. (1996). Motivational deficits after brain injury: effects of bromocriptine in 11 patients. J Neurol Neurosurg Psychiatry, 60(4), 416-421.

Rao, Jellinek, H. M., & Woolston, D. C. (1985). Agitation in closed head injury: Haloperidol effects on rehabilitation outcome. Arch Phys Med Rehabil, 66(1), 30-34.

Rapoport, M. J., Chan, F., Lanctot, K., Herrmann, N., McCullagh, S., & Feinstein, A. (2008). An open-label study of citalopram for major depression following traumatic brain injury. J Psychopharmacol, 22(8), 860-864.

Rapoport, M. J., Mitchell, R. A., McCullagh, S., Herrmann, N., Chan, F., Kiss, A., . . . Lanctôt, K. L. (2010). A randomized controlled trial of antidepressant continuation for major depression following traumatic brain injury. J Clin Psychiatry, 71(9), 1125-1130.

Rea, G. L., & Rockswold, G. L. (1983). Barbiturate therapy in uncontrolled intracranial hypertension. Neurosurgery, 12(4), 401-404.

Ritter, M. A., & Sieber, J. M. (1985). Prophylactic indomethacin for the prevention of heterotopic bone formation following total hip arthroplasty. Clin Orthop Relat Res, 196, 217-225.

Roberts, I. (2000). Barbiturates for acute traumatic brain injury. Cochrane Database Syst Rev, 2, Cd000033.

Roberts, I., Yates, D., Sandercock, P., Farrell, B., Wasserberg, J., Lomas, G., . . . Edwards, P. (2004). Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet, 364(9442), 1321-1328.

Rockoff, M. A., Marshall, L. F., & Shapiro, H. M. (1979). High-dose barbiturate therapy in humans: a clinical review of 60 patients. Ann Neurol, 6(3), 194-199.

Sanchez-Izquierdo-Riera, J. A., Caballero-Cubedo, R. E., Perez-Vela, J. L., Ambros-Checa, A., Cantalapiedra-Santiago, J. A., & Alted-Lopez, E. (1998). Propofol versus midazolam: safety and efficacy for sedating the severe trauma patient. Anesth Analg, 86(6), 1219-1224.

Saniova, B., Drobny, M., Kneslova, L., & Minarik, M. (2004). The outcome of patients with severe head injuries treated with amantadine sulphate. J Neural Transm, 111(4), 511-514.

Saul, T. G., Ducker, T. B., Salcman, M., & Carro, E. (1981). Steroids in severe head injury: A prospective randomized clinical trial. J Neurosurg, 54(5), 596-600.

Sawyer, E., Mauro, L. S., & Ohlinger, M. J. (2008). Amantadine enhancement of arousal and cognition after traumatic brain injury. Ann Pharmacother, 42(2), 247-252.

Sayre, M. R., Daily, S. W., Stern, S. A., Storer, D. L., van Loveren, H. R., & Hurst, J. M. (1996). Out-of-hospital administration of mannitol to head-injured patients does not change systolic blood pressure. Acad Emerg Med, 3(9), 840-848.

Scalfani, M. T., Dhar, R., Zazulia, A. R., Videen, T. O., & Diringer, M. N. (2012). Effect of osmotic agents on regional cerebral blood flow in traumatic brain injury. J Crit Care, 27(5), 526.e527-512.

Schalen, W., Sonesson, B., Messeter, K., Nordstrom, G., & Nordstrom, C. H. (1992). Clinical outcome and cognitive impairment in patients with severe head injuries treated with barbiturate coma. Acta Neurochir (Wien), 117(3-4), 153-159.

Schierhout, G., & Roberts, I. (2001). Anti-epileptic drugs for preventing seizures following acute traumatic brain injury. Cochrane Database Syst Rev, 4, Cd000173.

Schneider, W. N., Drew-Cates, J., Wong, T. M., & Dombovy, M. L. (1999). Cognitive and behavioural efficacy of amantadine in acute traumatic brain injury: an initial double-blind placebo-controlled study. Brain Inj, 13(11), 863-872.

Scholz, J., Bause, H., Schulz, M., Klotz, U., Krishna, D. R., Pohl, S., & Schulte am Esch, J. (1994). Pharmacokinetics and effects on intracranial pressure of sufentanil in head trauma patients. Br J Clin Pharmacol, 38(4), 369-372.

Schwartz, M. L., Tator, C. H., Rowed, D. W., Reid, S. R., Meguro, K., & Andrews, D. F. (1984). The University of Toronto head injury treatment study: a prospective, randomized comparison of pentobarbital and mannitol. Can J Neurol Sci, 11(4), 434-440.

Servit, Z., & Musil, F. (1981). Prophylactic treatment of posttraumatic epilepsy: Results of a long-term follow-up in Czechoslovakia. Epilepsia, 22(3), 315-320.

Shakeri, M., Boustani, M. R., Pak, N., Panahi, F., Salehpour, F., Lotfinia, I., . . . Taghiloo, D. (2013). Effect of progesterone administration on prognosis of patients with diffuse axonal injury due to severe head trauma. Clin Neurol Neurosurg, 115(10), 2019-2022.

Shohami, E., Novikov, M., & Bass, R. (1995). Long-term effect of HU-211, a novel non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat. Brain Res, 674(1), 55-62.

Simpson, G. K., Sabaz, M., & Daher, M. (2013). Prevalence, clinical features, and correlates of inappropriate sexual behavior after traumatic brain injury: A multicenter study. J Head Trauma Rehabil, 28(3), 202-210.

Smith, H. P., Kelly, D. L., Jr., McWhorter, J. M., Armstrong, D., Johnson, R., Transou, C., & Howard, G. (1986). Comparison of mannitol regimens in patients with severe head injury undergoing intracranial monitoring. J Neurosurg, 65(6), 820-824.

Sorani, M. D., Morabito, D., Rosenthal, G., Giacomini, K. M., & Manley, G. T. (2008). Characterizing the dose-response relationship between mannitol and intracranial pressure in traumatic brain injury patients using a high-frequency physiological data collection system. J Neurotrauma, 25(4), 291-298.

Speech, T. J., Rao, S. M., Osmon, D. C., & Sperry, L. T. (1993). A double-blind controlled study of methylphenidate treatment in closed head injury. Brain Inj, 7(4), 333-338.

Sperry, R. J., Bailey, P. L., Reichman, M. V., Peterson, J. C., Petersen, P. B., & Pace, N. L. (1992). Fentanyl and sufentanil increase intracranial pressure in head trauma patients. Anesthesiology, 77(3), 416-420.

Spielman, G., Gennarelli, T. A., & Rogers, C. R. (1983). Disodium etidronate: its role in preventing heterotopic ossification in severe head injury. Arch Phys Med Rehabil, 64(11), 539-542.

Stanislav, S. W., & Childs, A. (2000). Evaluating the usage of droperidol in acutely agitated persons with brain injury. Brain Inj, 14(3), 261-265.

Stein, D. G. (2008). Progesterone exerts neuroprotective effects after brain injury. Brain Res Rev, 57(2), 386-397.

Steinbaugh, L. A., Lindsell, C. J., Shutter, L. A., & Szaflarski, J. P. (2012). Initial EEG predicts outcomes in a trial of levetiracetam vs. fosphenytoin for seizure prevention. Epilepsy Behav, 23(3), 280-284.

Stewart, L., Bullock, R., Rafferty, C., Fitch, W., & Teasdale, G. M. (1994). Propofol sedation in severe head injury fails to control high ICP, but reduces brain metabolism. Acta Neurochir Suppl (Wien), 60, 544-546.

Stokic, D. S., Yablon, S. A., & Hayes, A. (2005). Comparison of clinical and neurophysiologic responses to intrathecal baclofen bolus administration in moderate-to-severe spasticity after acquired brain injury. Arch Phys Med Rehabil, 86(9), 1801-1806.

Stover, J. F., & Stocker, R. (1998). Barbiturate coma may promote reversible bone marrow suppression in patients with severe isolated traumatic brain injury. Eur J Clin Pharmacol, 54(7), 529-534.

Szaflarski, J. P., Nazzal, Y., & Dreer, L. E. (2014). Post-traumatic epilepsy: Current and emerging treatment options. Neuropsychiatr Dis Treat, 10, 1469-1477.

Temkin, N. R., Dikmen, S. S., Anderson, G. D., Wilensky, A. J., Holmes, M. D., Cohen, W., . . . Winn, H. R. (1999). Valproate therapy for prevention of posttraumatic seizures: A randomized trial. J Neurosurg, 91(4), 593-600.

Temkin, N. R., Dikmen, S. S., Wilensky, A. J., Keihm, J., Chabal, S., & Winn, H. R. (1990). A randomized, double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med, 323(8), 497-502.

Temkin, N. R., Haglund, M. M., & Winn, H. R. (1995). Causes, prevention, and treatment of post-traumatic epilepsy. New Horiz, 3(3), 518-522.

Thorat, J. D., Wang, E. C., Lee, K. K., Seow, W. T., & Ng, I. (2008). Barbiturate therapy for patients with refractory intracranial hypertension following severe traumatic brain injury: its effects on tissue oxygenation, brain temperature and autoregulation. J Clin Neurosci, 15(2), 143-148.

Tidwell, A., & Swims, M. (2003). Review of the newer antiepileptic drugs. Am J Manag Care, 9(3), 253-276.

US Modafinil in Narcolepsy Multicenter Study Group (1998). Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. Ann Neurol, 43(1), 88-97.

US Modafinil in Narcolepsy Multicenter Study Group (2000). Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology, 54(5), 1166-1175.

Volavka, J., Czobor, P., Nolan, K., Sheitman, B., Lindenmayer, J. P., Citrome, L., . . . Lieberman, J. A. (2004). Overt Aggression and Psychotic Symptoms in Patients with Schizophrenia Treated with Clozapine, Olanzapine, Risperidone, or Haloperidol. J Clin Psychopharmacol, 24(2), 225-228.

Wakai, A., Roberts, I., & Schierhout, G. (2005). Mannitol for acute traumatic brain injury. Cochrane Database Syst Rev, 4, Cd001049.

Walker, W., Seel, R., Gibellato, M., Lew, H., Cornis-Pop, M., Jena, T., & Silver, T. (2004). The effects of Donepezil on traumatic brain injury acute rehabilitation outcomes. Brain Inj, 18(8), 739-750.

Ward, J. D., Becker, D. P., Miller, J. D., Choi, S. C., Marmarou, A., Wood, C., . . . Keenan, R. (1985). Failure of prophylactic barbiturate coma in the treatment of severe head injury. J Neurosurg, 62(3), 383-388.

Watanabe, T. K., & Sant, M. O. (2001). Common medical complications of traumatic brain injury. Physical Medicine and Rehabilitation: state of the art reviews, 15, 283-299.

Watson, N. F., Barber, J. K., Doherty, M. J., Miller, J. W., & Temkin, N. R. (2004). Does glucocorticoid administration prevent late seizures after head injury? Epilepsia, 45(6), 690-694.

Webb, P. M., & Glueckauf, R. L. (1994). The effects of direct involvement in goal setting on rehabilitation outcome for persons with traumatic brain injuries. Rehabilitation Psychology, 39(3), 179-188.

Werner, C., Kochs, E., Bause, H., Hoffman, W. E., & Schulte am Esch, J. (1995). Effects of sufentanil on cerebral hemodynamics and intracranial pressure in patients with brain injury. Anesthesiology, 83(4), 721-726.

Whyte, J., Hart, T., Vaccaro, M., Grieb-Neff, P., Risser, A., Polansky, M., & Coslett, H. B. (2004). Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial. Am J Phys Med Rehabil, 83(6), 401-420.

Whyte, J., Katz, D., Long, D., DiPasquale, M. C., Polansky, M., Kalmar, K., . . . Eifert, B. (2005). Predictors of outcome in prolonged posttraumatic disorders of consciousness and assessment of medication effects: A multicenter study. Arch Phys Med Rehabil, 86(3), 453-462.

Whyte, J., Vaccaro, M., Grieb-Neff, P., Hart, T., Polansky, M., & Coslett, H. B. (2008). The effects of bromocriptine on attention deficits after traumatic brain injury: a placebo-controlled pilot study. Am J Phys Med Rehabil, 87(2), 85-99.

Williams, S. E., Ris, M. D., Ayyangar, R., Schefft, B. K., & Berch, D. (1998). Recovery in pediatric brain injury: is psychostimulant medication beneficial? J Head Trauma Rehabil, 13(3), 73-81.

Willmott, C., & Ponsford, J. (2009). Efficacy of methylphenidate in the rehabilitation of attention following traumatic brain injury: a randomised, crossover, double blind, placebo controlled inpatient trial. J Neurol Neurosurg Psychiatry, 80: 552-557.

Willmott, C., Ponsford, J., McAllister, T. W., & Burke, R. (2013). Effect of COMT Val158Met genotype on attention and response to methylphenidate following traumatic brain injury. Brain Inj, 27(11), 1281-1286.

Wright, D. W., Kellermann, A. L., Hertzberg, V. S., Clark, P. L., Frankel, M., Goldstein, F. C., . . . Stein, D. G. (2007). ProTECT: a randomized clinical trial of progesterone for acute traumatic brain injury. Ann Emerg Med, 49(4), 391-402, 402.e391-392.

Wright, D. W., Yeatts, S. D., Silbergleit, R., Palesch, Y. Y., Hertzberg, V. S., Frankel, M., . . . Barsan, W. G. (2014). Very early administration of progesterone for acute traumatic brain injury. N Engl J Med, 371(26), 2457-2466.

Wroblewski, B. A., & Joseph, A. B. (1992). The use of intramuscular midazolam for acute seizure cessation or behavioral emergencies in patients with traumatic brain injury. Clin Neuropharmacol, 15(1), 44-49.

Wroblewski, B. A., Joseph, A. B., & Cornblatt, R. R. (1996). Antidepressant pharmacotherapy and the treatment of depression in patients with severe traumatic brain injury: a controlled, prospective study. J Clin Psychiatry, 57(12), 582-587.

Wroblewski, B. A., Joseph, A. B., Kupfer, J., & Kalliel, K. (1997). Effectiveness of valproic acid on destructive and aggressive behaviours in patients with acquired brain injury. Brain Inj, 11(1), 37-47.

Xiao, G., Wei, J., Yan, W., Wang, W., & Lu, Z. (2008). Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: a randomized controlled trial. Crit Care, 12(2), R61.

Yablon, S. A., Agana, B. T., Ivanhoe, C. B., & Boake, C. (1996). Botulinum toxin in severe upper extremity spasticity among patients with traumatic brain injury: an open-labeled trial. Neurology, 47(4), 939-944.

Young, B., Rapp, R. P., Norton, J. A., Haack, D., Tibbs, P. A., & Bean, J. R. (1983a). Failure of prophylactically administered phenytoin to prevent early posttraumatic seizures. J Neurosurg, 58(2), 231-235.

Young, B., Rapp, R. P., Norton, J. A., Haack, D., Tibbs, P. A., & Bean, J. R. (1983b). Failure of prophylactically administered phenytoin to prevent late posttraumatic seizures. J Neurosurg, 58(2), 236-241.

Zafar, S. N., Khan, A. A., Ghauri, A. A., & Shamim, M. S. (2012). Phenytoin versus Leviteracetam for seizure prophylaxis after brain injury - a meta analysis. BMC Neurol, 12, 30.

Zafonte, R. D., Lexell, J., & Cullen, N. (2001). Possible applications for dopaminergic agents following traumatic brain injury: part 2. J Head Trauma Rehabil, 16(1), 112-116.

Zhang, L., Plotkin, R. C., Wang, G., Sandel, M. E., & Lee, S. (2004). Cholinergic augmentation with donepezil enhances recovery in short-term memory and sustained attention after traumatic brain injury. Arch Phys Med Rehabil, 85(7), 1050-1055.